Interventions for waterpipe smoking cessation
- PMID: 26228266
- PMCID: PMC4838024
- DOI: 10.1002/14651858.CD005549.pub3
Interventions for waterpipe smoking cessation
Update in
-
Interventions for waterpipe smoking cessation.Cochrane Database Syst Rev. 2023 Jun 7;6(6):CD005549. doi: 10.1002/14651858.CD005549.pub4. Cochrane Database Syst Rev. 2023. PMID: 37286509 Free PMC article. Review.
Abstract
Background: Waterpipe tobacco smoking is a traditional method of tobacco use, especially in the Eastern Mediterranean Region (EMR), but its use is now spreading worldwide. Recent epidemiological data, for example, show that waterpipe smoking has become the most prevalent tobacco use method among adolescents in the EMR, and the second most prevalent in the US. Waterpipes are used socially, often being shared between friends or family at home, or in dedicated bars and cafes that provide waterpipes to patrons. Because the smoke passes through a reservoir of water, waterpipe tobacco smoking is perceived as being less harmful than other methods of tobacco use. At least in some cultures, women and girls are more likely to use a waterpipe than to use other forms of tobacco, and it is popular among younger smokers. Accumulating evidence suggests that some waterpipe smokers become addicted, have difficulty quitting, and experience similar health risks as cigarette smokers.
Objectives: To evaluate the effectiveness of tobacco cessation interventions for waterpipe users.
Search methods: We searched the Cochrane Tobacco Addiction Review Group specialized register in June 2015. We also searched MEDLINE, EMBASE, PsycINFO and CINAHL , using variant terms and spellings ('waterpipe' or 'narghile' or 'arghile' or 'shisha' or 'goza' or 'narkeela' or 'hookah' or 'hubble bubble'). We searched for trials, published or unpublished, in any language, and especially in regions where waterpipe use is widespread.
Selection criteria: We sought randomized, quasi-randomized or cluster-randomized controlled trials of smoking cessation interventions for waterpipe smokers of any age or gender. The primary outcome of interest was abstinence from tobacco use, measured at six months post-cessation or longer, regardless of whether abstinence was biochemically verified. We included interventions that were pharmacological (for example, nicotine replacement therapy (NRT) or bupropion) or behavioural, or both, and could be directed at individual waterpipe users or at groups of users. We only included tobacco cessation interventions, and did not consider trials of prevention of uptake.
Data collection and analysis: Two review authors assessed abstracts of the studies retrieved by the search strategy, for possible inclusion in the review. We retrieved full-text articles for all abstracts that any of the authors believed might be suitable. Two review authors then extracted data and assessed trial quality independently in accordance with standard Cochrane Collaboration methodologies. We aimed to pool groups of studies that we considered to be sufficiently similar, provided there was no evidence of substantial statistical heterogeneity, and aimed to estimate a pooled risk ratio (RR) using the Mantel-Haenszel fixed-effect method. Where meta-analysis was not possible, we presented summary and descriptive statistics.
Main results: Our search retrieved 1311 unique citations, of which 1289 were excluded after title and abstract screening. Of the remaining 22, we excluded 19 because they were empirical studies that were not randomized, quasi-randomized or cluster-randomized controlled trials (n = 12), because they were review articles (n = 3), because they described protocols only (n = 2), they were conducted among cigarette smokers only (n = 1), or they had only a three-month follow-up (n = 1).We identified three controlled trials which tested cessation interventions for waterpipe smokers. Studies were carried out in Egypt (Mohlman 2013), Pakistan (Dogar 2014), and the US (Lipkus 2011). One was a randomized controlled trial and two were cluster-randomized trials. Two studies tested individual-level interventions, and one tested a community-level intervention. Two studies included only behavioural interventions, and one study (Dogar 2014) included two intervention groups: one behavioural, and the other behavioural with bupropion. The Lipkus and Mohlman studies delivered waterpipe-specific interventions, and the Dogar study delivered a non-specific tobacco intervention. Due to study variation we did not pool results, and intervention effects are reported descriptively. Compared to control groups, waterpipe smoking cessation rates were higher in the intervention groups in all three studies, with a significant difference in two studies. For the Dogar study, the RRs for waterpipe smoking abstinence at 25 weeks among waterpipe-only smokers were 2.2 (95% confidence interval (CI) 1.3 to 3.8; 180 participants) in the behavioural group, and 2.5 (95% CI 1.3 to 4.7; 84 participants) in the behavioural plus bupropion group. In our analysis we have combined both groups, to give a RR of 2.28 (95% CI 1.36 to 3.83; 200 participants). The Mohlman study delivered a RR in male waterpipe-smokers at one year in favour of the intervention of 3.25 (95% CI 1.19 to 8.89).
Authors' conclusions: Although the literature on waterpipe cessation interventions remains sparse, the reviewed studies provide a basis for developing interventions in this area. The lack of statistically significant effects in one of the three studies is not unexpected, given the small and pilot nature of the studies. The studies highlight important design and content issues that need to be considered for future cessation trials in waterpipe smokers. These include building on the vast experience developed in the study of smoking cessation interventions in cigarette smokers, whilst including components and assessment tools that address the specific aspects of waterpipe smoking, such as its social dimension, unique experiences, and cues.
Conflict of interest statement
KW has no known conflicts of interest MJ has no known conflicts of interest SJ has no known conflicts of interest TA has no known conflicts of interest WM is funded by National Institute on Drug Abuse (NIDA) grant R01 DA035160. WM's research in tobacco control, including the waterpipe, has been funded by the US National Institutes of Health since 2002. TE's research on waterpipe tobacco smoking and various other tobacco products, including electronic cigarettes, has been supported by grants from the U.S. National Institutes of Health and is currently supported by the U.S. National Institutes of Health's National Institute on Drug Abuse and the Center for Tobacco Products of the US Food and Drug Administration (P50DA036105). TE also occasionally receives honoraria for delivering invited lectures regarding tobacco product effects to a variety of university audiences. The content of the work published herein is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Food and Drug Administration.
Figures
Update of
-
Interventions for waterpipe smoking cessation.Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005549. doi: 10.1002/14651858.CD005549.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2015 Jul 31;(7):CD005549. doi: 10.1002/14651858.CD005549.pub3. PMID: 17943865 Updated. Review.
Similar articles
-
Interventions for waterpipe smoking cessation.Cochrane Database Syst Rev. 2023 Jun 7;6(6):CD005549. doi: 10.1002/14651858.CD005549.pub4. Cochrane Database Syst Rev. 2023. PMID: 37286509 Free PMC article. Review.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Smoking cessation interventions for smokers with current or past depression.Cochrane Database Syst Rev. 2013 Aug 21;(8):CD006102. doi: 10.1002/14651858.CD006102.pub2. Cochrane Database Syst Rev. 2013. PMID: 23963776 Review.
-
Interventions for waterpipe smoking cessation.Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005549. doi: 10.1002/14651858.CD005549.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2015 Jul 31;(7):CD005549. doi: 10.1002/14651858.CD005549.pub3. PMID: 17943865 Updated. Review.
-
Tobacco cessation interventions for young people.Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003289. doi: 10.1002/14651858.CD003289.pub4. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2013 Aug 23;(8):CD003289. doi: 10.1002/14651858.CD003289.pub5. PMID: 17054164 Updated. Review.
Cited by
-
Interventions for waterpipe smoking cessation.Cochrane Database Syst Rev. 2023 Jun 7;6(6):CD005549. doi: 10.1002/14651858.CD005549.pub4. Cochrane Database Syst Rev. 2023. PMID: 37286509 Free PMC article. Review.
-
Prevalence of Tobacco Smoking and Associated Risk Factors Among Public Sector Employees in Kuwait: A Cross-Sectional Study.Cureus. 2023 Mar 9;15(3):e35925. doi: 10.7759/cureus.35925. eCollection 2023 Mar. Cureus. 2023. PMID: 37038574 Free PMC article.
-
Correlates of motivation to quit waterpipe tobacco smoking among US young adults: implications for cessation interventions.Health Educ Res. 2023 Jul 25;38(4):338-349. doi: 10.1093/her/cyad010. Health Educ Res. 2023. PMID: 36880171 Free PMC article.
-
[Epidemiology of smoking in the male population in Tunisia. HSHS Study 6].Tunis Med. 2022 Octobre;100(10):683-695. Tunis Med. 2022. PMID: 36571753 Free PMC article. French.
-
Prevalence of smoking (cigarette and waterpipe) and its association with obesity/overweight in UAE and Palestine.Front Public Health. 2022 Oct 21;10:963760. doi: 10.3389/fpubh.2022.963760. eCollection 2022. Front Public Health. 2022. PMID: 36339216 Free PMC article.
References
References to studies included in this review
Dogar 2014 {published data only}
-
- Dogar O, Jawad M, Shah SK, Newell JN, Kanaan M, Khan MA, et al. Effect of cessation interventions on hookah smoking: post‐hoc analysis of a cluster‐randomized controlled trial. Nicotine & Tobacco Research 2014;16(6):682‐8. - PubMed
-
- Siddiqi K, Khan A, Ahmad M, Dogar O, Kanaan M, Newell JN, et al. Action to stop smoking in suspected tuberculosis (ASSIST)in Pakistan: a cluster randomized, controlled trial. Annals of Internal Medicine 2013;158(9):667‐75. - PubMed
Lipkus 2011 {published and unpublished data}
References to studies excluded from this review
Additional references
Aboaziza 2015
Akl 2013
Akl 2015
Anjum 2008
-
- Anjum Q, Ahmed F, Ashfaq T. Knowledge, attitude and perception of water pipe smoking (Shisha) among adolescents aged 14‐19 years. The Journal of the Pakistan Medical Association 2008;58(6):312. - PubMed
Arrazola 2015
Asfar 2008
-
- Asfar T, Weg MV, Maziak W, Hammal F, Eissenberg T, Ward KD. Outcomes and adherence in Syria's first smoking cessation trial. American Journal of Health Behavior 2008;32(2):146‐56. - PubMed
Borgan 2013
-
- Borgan SM, Marhoon ZA, Whitford DL. Beliefs and perceptions toward quitting waterpipe smoking among café waterpipe tobacco smokers in Bahrain. Nicotine & Tobacco Research 2013;15(11):1816‐21. - PubMed
El‐Zaatari 2015
GYTS 2003
-
- Global Youth Tobacco Survey Collaborating Group. Differences in worldwide tobacco use by gender: findings from the global youth tobacco survey. Journal of School Health 2003;73(6):207‐15. - PubMed
Higgins 2003
Hughes 2003
-
- Hughes JR, Keely JP, Niaura RS, Ossip‐Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine & Tobacco Research 2003;5(1):13‐25. - PubMed
Jarvis 1988
Jawad 2013
-
- Jawad M, Jawad S, Mehdi A, Sardar A, Jawad AM, Hamilton FL. A qualitative analysis among regular waterpipe tobacco smokers in London universities. The International Journal of Tuberculosis and Lung Disease 2013;17(10):1364‐9. - PubMed
Jawad 2015
Lancaster 2005
Martinasek 2011
-
- Martinasek MP, McDermott RJ, Martini L. Waterpipe (hookah) tobacco smoking among youth. Current Problems in Pediatric and Adolescent Health Care 2011;41(2):34‐57. - PubMed
Maziak 2004
Maziak 2015
Murray 1987
-
- Murray DM, O'Connell CM, Schmid LA, Perry CL. The validity of smoking self‐reports by adolescents: a reexamination of the bogus pipeline procedure. Addictive Behaviors 1987;12(1):7‐15. - PubMed
Patrick 1994
Peto 2001
-
- Peto R, Lopez AD. Future worldwide health effects of current smoking patterns. In: Koop CE, Pearson CE, Schwarz MR editor(s). Critical Issues in Global Health. San Francisco CA: Jossey‐Bass, 2001.
Primack 2009
Salameh 2008
-
- Salameh P, Waked M, Aoun Z. Waterpipe smoking: construction and validation of the Lebanon Waterpipe Dependence Scale (LWDS‐11). Nicotine and Tobacco Research 2008;10(1):149‐58. - PubMed
Shihadeh 2015
SRNT 2002
-
- SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research 2002;4(2):149‐59. - PubMed
Ward 2005
-
- Ward KD, Hammal F, VanderWeg MW, Eissenberg T, Asfar T, Rastam S, et al. Are waterpipe users interested in quitting?. Nicotine & Tobacco Research 2005;7(1):149‐56. - PubMed
Ward 2006
Ward 2014
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources